Showing results (2451-2460 of 10,080) with videos related to

Sort By:
Pageof 1,008
Current Pharmaceutical Design|August 19, 2026
Data Collection and Management for AI-Based Pharmaceutical Formulation Development: A Comprehensive ReviewPritam Kayal, Priyam Manna, Ramit Rahaman, et al.
Current Pharmaceutical Design|September 11, 2026
Targeting the Immune System with Nanoparticles: A Comprehensive Review on ImmunomodulationMuhammad Saad Latif, Fahad Ali Noori, Muhammad Saqlain Mushtaq, et al.
Current Pharmaceutical Design|August 24, 2026
Carvedilol Beyond the Heart: Pleiotropic Mechanisms and Emerging Therapeutic Applications Across Organ SystemsDhirendra Singh, Joy Oladimeji-Salami, Abidemi James Akindele
Current Pharmaceutical Design|August 24, 2026
Designing Intelligent Antibacterial Systems via Piezoelectric Catalysis: Mechanisms and Pharmaceutical PerspectivesManaf AlMatar, Imen Ben Abdelmalek, Raja Lakhal
Current Pharmaceutical Design|October 9, 2026
Phytochemical Composition, Pharmacological Activities, and Clinical Evidence of Bacopa monnieri in Cognitive and Memory EnhancementBhagavathi Sundaram Sivamaruthi, Periyanaina Kesika, Karthikeyan Alagarsamy, et al.
Current Pharmaceutical Design|September 4, 2026
Artificial Intelligence-Driven Diagnosis, Prediction, and Management of Polycystic Ovarian Disease (PCOD): A Comprehensive Systematic Review of Machine Learning, Deep Learning, and Emerging TechnologiesAnkita Wal, Mekala Moorthy, Rakesh Verma, et al.
Current Pharmaceutical Design|September 4, 2026
Identification of the Potential of Plant-Derived Agents to Act as KRAS G12D Inhibitors Through Molecular Docking, Molecular Dynamics Simulations, and MMGBSAEbru Okutan, Serra Özışık, Vildan Enisoglu Atalay
Current Pharmaceutical Design|September 4, 2026
Traditional Chinese Medicine for Diabetic Cardiomyopathy: Multitarget Mechanisms and Translational PotentialFenghua Qu, Qin Yuan, Yulan Shi, et al.
Current Pharmaceutical Design|August 31, 2026
Transforming Growth Factor β3 (TGF-β3) Signaling: A Potential Target for Cancer TherapyZan-Wen Zuo, Wen-Jing Tang, Qian Zhang, et al.
Current Pharmaceutical Design|November 3, 2026
In silico Design and Molecular Modeling of Piperazine-Oxadiazole Appended Imidazo[2,1-b][1,3,4]Thiadiazoles as Promising RTK InhibitorsG Shivaraja, Ghadah Aljohani, Fadzilah Adibah Abdul Majid, et al.
Pageof 1,008